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Introduction
Intermediary metabolism, particularly catabolism of glucose, is 
central to normal cell function and is dysregulated in diseases 
such as cancer, diabetes, and neurodegenerative disorders. The 
cell biology of cytosolic metabolic enzymes, particularly their 
spatial organization, is critical for understanding normal and 
dysregulated metabolism but remains relatively understudied. 
Emerging evidence indicates that several cytosolic metabolic 
enzymes assemble into filamentous polymers for spatial and 
temporal organization. Filament assembly has been reported 
for several mammalian cytosolic metabolic enzymes, includ-
ing acetyl-coA carboxylase (Meredith and Lane, 1978; Beaty 
and Lane, 1983), glutamine synthase (Frey et al., 1975), glu-
tamate dehydrogenase (Eisenberg and Tomkins, 1968; Cohen 
et al., 1976), glutaminase (Olsen et al., 1970), β-glucosidase 
(Gunning, 1965; Kim et al., 2005), and cytidine triphosphate 
(CTP) synthase (Ingerson-Mahar et al., 2010; Liu, 2010; Noree 
et al., 2010; Habrian et al., 2016). Filament assembly by met-
abolic enzymes is not restricted to mammalian cells but is also 
seen in yeasts and bacteria (O’Connell et al., 2012; Shen et al., 
2016), suggesting conserved biological processes. Several not 
necessarily exclusive functions for the evolution of metabolic 
enzyme filaments from bacteria to mammalian cells have been 
proposed (O’Connell et al., 2012). In some cases, assembly has 
a direct effect on enzyme activity and is believed to provide an 
additional layer of regulation in response to changing metabolic 
conditions; for example, bacterial CTP synthase is inactivated 
in the filament form (Barry et al., 2014). One function that is 
shared by filamentous assemblies of nonmetabolic enzymes is 
to maximize catalytic efficiency by channeling or funneling be-
tween active sites. An additional speculated function is to limit 
diffusion to enable a localized metabolic platform. Moreover, 
filaments of bacterial CTP synthase are also reported to have a 
structural role in cell shape (Ingerson-Mahar et al., 2010).
Glycolysis is an ancient metabolic pathway for process-
ing glucose into pyruvate, generating energy in the form of 
ATP and NADH as well as anabolic building blocks for nu-
cleotides, amino acids, and lipids. Glycolytic enzymes function 
as highly regulated molecular machines that fine-tune the rate 
of glucose utilization and are dysregulated as well as mutated 
in cancer. The committed step of glycolysis is catalyzed by 
phosphofructokinase-1 (PFK1). PFK1 was recently identified 
as a filament-forming enzyme in Saccharomyces cerevisiae 
(Shen et al., 2016). Filament formation by PFK1 may be evolu-
tionarily conserved because purified liver PFK1 (PFKL) forms 
asymmetric oligomers in vitro, as determined by gel chroma-
tography (Kemp, 1971), sedimentation with analytical ultracen-
trifugation (Trujillo and Deal, 1977), fluorescence polarization 
(Reinhart and Lardy, 1980), and fluorescence correlation spec-
troscopy (Ranjit et al., 2014). However, only one previous study 
showed filamentous structures by transmission EM (TEM; Foe 
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and Trujillo, 1980), and this study did not address three im-
portant unknowns: whether filament assembly is regulated, 
the alignment of PFKL tetramers within the filaments, and 
whether filament formation occurs in cells. We now resolve 
these unknowns by showing the regulated assembly of PFKL 
filaments, their higher-order quaternary structure determined 
from negative-stain electron micrographs, and the dynamic 
behavior of punctate PFKL-EGFP particles in cells quantified 
from time-lapse imaging.
Results and discussion
We recently reported the first biologically relevant tetrameric 
mammalian PFK1 structure using recombinant platelet PFK1 
(PFKP) produced using a baculovirus expression system (Webb 
et al., 2015). We used the same system to express and purify the 
liver and muscle isoforms of PFK1. While performing crystal-
lization studies, we were unable to obtain highly concentrated 
PFKL, whereas PFKP was stable at a high concentration (>30 
mg/ml). Because concentration-dependent aggregation is a 
hallmark of self-associating proteins, we sought to determine 
whether PFKL assembles into higher-order oligomers.
Baculovirus-expressed PFK1 isoforms were purified to 
homogeneity, as determined by Coomassie-stained SDS-PAGE 
gels (Fig. S1 A), and were tetrameric, as shown by TEM (Figs. 
1 A and S1 B). All three recombinant enzymes showed isoform- 
specific activity and regulation, including sensitivity to inhi-
bition by ATP and activation by the sugar substrate fructose 
6-phosphate (F6P; Fig. S1, C–E). We visualized by TEM the 
quaternary structure of purified PFKL. In control buffer with 
1 mM ATP, pH 7.4, PFKL was predominantly tetrameric and 
was occasionally seen as small aggregates (Fig. 1 A). However, 
in the presence of 2 mM F6P, PFKL assembled into filaments 
(Fig. 1, B and C). Filaments were heterogeneous in length, with 
a mean length of 65.4 ± 34.1 nm (mean ± SD; n = 98 filaments; 
Fig. 1 D). This corresponds with ∼6 tetramers similar in scale 
with previous biophysical measurements (Reinhart and Lardy, 
1980). Some filaments displayed bends of a mean angle of 124 
± 18° (mean ± SD; n = 290 angles; Fig. 1, C and E). In contrast, 
F6P did not induce filament assembly of PFKP or muscle PFK1 
(PFKM; Fig. S1 B), indicating an isoform-specific behavior. The 
presence of tetramers in control buffer suggests that tetramer 
formation precedes the formation of the elongated polymer. 
Consistent with this prediction, a catalytically inactive PFKL-
Y638R mutant that does not form tetramers does not assemble 
into filaments in the presence of 2 mM F6P (Fig. S1, B and F).
The assembly of PFKL into higher-order structures was 
also determined by 90° light scattering. Addition of 2 mM F6P 
but not a control buffer induced a rapid increase in the intensity 
of light scattering followed by a stable plateau (Fig. 2, A and 
B). Titrating the concentration of PFKL (50–500 µg/ml; 0.6–
6.0 µM) showed a concentration-dependent increase in the rate 
and intensity of scattering at the plateau (Fig. 2 A). Filament 
formation as determined by TEM and oligomerization as deter-
mined by light scattering occurring at physiologically relevant 
concentrations of PFKL, which are estimated to be 20–50 µg/
ml (Reinhart and Lardy, 1980). Titrating F6P from 0–2 mM at 
200 µg/ml (2.4 µM) PFKL showed a concentration-dependent 
sigmoidal response to substrate. No increase in the intensity 
of scattering was observed at concentrations of <0.6 mM F6P 
(Fig. 2 B), an intermediate response occurred between 0.7 and 
0.8 mM F6P, and a maximal response occurred at concentra-
tions of >0.9 mM F6P. These concentrations were higher than 
the concentration of F6P in cells (∼100–350 µM; Albe et al., 
1990), suggesting additional factors may be required for the for-
mation of filaments in cells. Consistent with our TEM findings 
that PFKP and PFKM did not form filaments, 2 mM F6P did 
not increase light scattering with PFKP or PFKM (Fig. S1 G).
To confirm F6P-dependent assembly of PFKL filaments, 
we generated a PFKL mutant that was unable to bind F6P. 
Using our recently resolved PFKP crystal structure (Webb et 
al., 2015) as a guide, we identified His199 (His208 of PFKP) 
in the substrate-binding pocket as a critical residue for bind-
ing F6P (Fig.  2  C). We predicted that mutation of His199 to 
Tyr would occlude F6P from the binding pocket but not in-
Figure 1. PFKL forms filaments of stacked tet­
ramers. (A and B) TEM images of PFKL in con-
trol buffer (A) and in buffer containing 2 mM 
F6P (B). (C) Higher-magnification TEM image 
of a PFKL filament in the presence of 2  mM 
F6P. Red arrows highlight bends in the fila-
ment. (D) Chart of binned length determined 
relative to the percentage of filaments from 
98 PFKL filaments measured from two sepa-
rate protein preparations. The approximate 
number of tetramers that each bin represents 
is shown at the top of the chart. (E) Angle of 
bend determined relative to number of occur-
rences for a total of 290 bends measured from 
three separate protein preparations. The red 
line represents the mean of 124°.
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hibit tetramer formation. Consistent with an inability to bind 
to F6P, PFKL-H199Y was catalytically inactive (Fig. S1 F). 
TEM analysis showed that PFKL-H199Y was mainly tetram-
eric in control buffer and did not assemble into filaments with 
2 mM F6P (Fig. 2 D). Additionally, no increase in light scatter-
ing was observed with F6P (Fig. 2 E). Collectively, these data 
confirm that substrate binding is essential for the formation of 
PFKL filaments in vitro.
To better understand the PFKL filament architecture, we 
determined filament structure by negative-stain EM and iterative 
helical real-space reconstruction at 25-Å resolution (Fig. S2 A). 
The filament was formed from stacked tetramers that were re-
lated by a rotation of 221° and a translation of 83 Å between sub-
units (Fig. 3, A and B). Although we did not directly determine 
the hand of the PFKL filament by EM, the PFK crystal structure 
only fit well in the right-handed helix. The PFKL tetramer had 
D2 symmetry, with three perpendicular twofold symmetry axes; 
one twofold axis was perpendicular to the helical symmetry axis, 
whereas the other two were tilted ∼30° from the helical axis (Fig. 
S2, B and C). This arrangement resulted in different assembly 
interactions for each of the two dimers that make up the PFKL te-
tramer, which we refer to as dimers A and B. Although the overall 
approximate D2 symmetry of the PFKL tetramer remained in-
tact, the resolution of our structure was insufficient to visualize 
small conformational differences in dimers A and B that may 
arise from their unique packing environments in the polymer; 
such asymmetry, however, would be consistent with asymmetry 
observed in PFKP crystal structures (Webb et al., 2015). The 
asymmetry in assembly interfaces between the A and B dimers 
of PFKL was unusual among helical filaments with multimeric 
helical asymmetric units. Typically, each protomer makes iden-
tical assembly contacts, although asymmetries like the one seen 
in this study have been seen previously (Egelman et al., 2015).
Two different surfaces of the C-terminal regulatory do-
main mediate the interaction of PFKL tetramers in filaments. 
Although the resolution of the structure prevents a precise de-
scription of the assembly interface, the approximate regions are 
residues (PFKL numbering) 396–401, 476–490, 510–519, and 
693–705 (interface 1; red) and residues 327–354, 372–377, and 
712–718 (interface 2; orange; Fig. S2, D and E; and Fig. S3 A). 
Longitudinal contacts between PFKL tetramers alternate along 
the filament, with interface 2 of A dimers interacting with in-
terface 1 of B dimers. In B dimers, interface 2 was exposed, 
whereas in A dimers, interface 1 made contact with interface 1 
of the A dimer in the next subunit along the filament (Figs. 3 C 
and S2, D and E). This unusual helical symmetry meant that the 
last subunit in a polymer presented two different but mutually 
exclusive assembly interfaces for the addition of another sub-
unit; addition at one site produced a linear filament, whereas 
addition at the other introduced a kink of ∼130° into the fila-
ment (Fig. 3 D). This closely matched the bends we observed in 
filaments (Fig. 1, C and E). 2D reference-free averages of PFKL 
filament segments revealed well-ordered classes with defined 
kinks (Fig. 3 E), suggesting that the kinked assembly interac-
tions happen frequently and that the bends observed in PFKL 
filaments are not the result of inherent flexibility but rather re-
flect alternate assembly contacts. The formation of polymers 
with irregular long-range structure may reflect a lack of con-
straints on PFKL architecture and suggests that assembled fil-
aments may be more important for aggregating PFKL subunits 
than for organization into a specific configuration.
Based on the observed contact sites between tetramers, 
we tested whether the regulatory domain of PFKL is sufficient 
for filament formation. We generated a chimera containing the 
catalytic region of PFKP (amino acids 1–368) and the regula-
tory region of PFKL (amino acids 360–780; CatP/RegL; Figs. 3 
Figure 2. PFKL filament formation is concentration­ and F6P­dependent. (A) 90° light scattering of 50–500 µg/ml PFKL upon the addition of 2 mM F6P 
at time 0. Red, 50 µg/ml; orange, 100 µg/ml; green, 150 µg/ml; blue, 200 µg/ml; purple, 400 µg/ml; black, 500 µg/ml. (B) 90° light scattering at the 
200 µg/ml PFKL upon the addition of the indicated concentration of F6P at time 0. Red, 0 mM; orange, 0.25 mM; pink, 0.5 mM; green, 0.6 mM; purple, 
0.7 mM; maroon, 0.75 mM; dark blue, 0.8 mM; light blue, 0.9 mM; dark green, 1.0 mM; light gray, 1.25 mM; dark gray, 1.5 mM; black, 2.0 mM. 
(C) Location of His199 in the F6P binding pocket of PFK1. (D) TEM images of PFKL-H199Y in control buffer (left) and in buffer containing 2 mM F6P (right). 
(E) 90° light scattering at 200 µg/ml PFKL or PFKL-H199Y upon the addition of 2 mM F6P at time 0. Data are representative of three determinations from 
two separate protein preparations.
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F and S3 A). Recombinant CatP/RegL was catalytically active 
(Fig. S3, B and C) but less stable than the wild-type protein, and 
it required addition of 5 mM of the allosteric activator ammo-
nium sulfate to maintain protein stability and activity (unpub-
lished data). In the presence but not the absence of F6P, CatP/
RegL formed elongated filaments as visualized by TEM, and 
the 3D reconstruction was essentially identical to the PFKL 
filament structure (Fig. 3, G and H). Additionally, 2 mM F6P 
but not control buffer induced an increase in light scattering 
(Fig.  3  I). Collectively, these results are consistent with our 
TEM data and confirm that the residues required for filament 
formation are in the regulatory region of PFKL.
We also asked whether PFKL forms higher-order struc-
tures in cells by expressing EGFP-tagged PFK1 isoforms in rat 
carcinoma MTLn3 cells. High-speed total internal reflection 
fluorescence (TIRF) microscopy at 5–10-frames-per-second ac-
quisition rates revealed that PFKL has a punctate localization 
in cells (Fig. 4 A and Video 1). Because of the high density 
of the particle field and movement of PFKL-EGFP in and out 
of the TIRF plane, it was not possible to track individual par-
ticles, but the majority of PFKL-EGFP particles appeared to 
move around the cytoplasm in a nondirected fashion, likely by 
Brownian diffusion. However, further analysis of PFKL-EGFP 
time-lapse sequences by applying rolling averages of 1–5-s 
temporal windows to average highly mobile particles identified 
a smaller population of more stable PFKL-EGFP that remained 
stationary for several seconds and were clearly visible on kymo-
graphs of nonaveraged data (Fig. 4, B and C). Because the TIRF 
excitation plane is only a few hundred nanometers thick, these 
stationary PFKL-EGFP particles likely represent temporary 
docking events at or near the ventral plasma membrane. Fur-
thermore, some PFKL-EGFP particles were seen to pause at the 
same location proximal to the membrane (Fig. 4 D), suggest-
ing that the docking site can remain stationary. The identity of 
Figure 3. Architecture of PFKL filament. (A) Negative-stain 3D reconstruction of the PFKL at 25-Å resolution. The PFKL tetramer is the repeating helical 
unit. Dimers on each half of the tetramer, colored blue or green, are engaged in different assembly contacts. (B) Fit of the PFKP crystal structure into the EM 
structure, with distinct A and B dimers labeled. (C) Diagram of longitudinal interactions between A and B dimers. (D) PFKL tetramers can add to the end of 
a filament through interfaces 1 or 2, resulting in either a continued linear polymer or a kink of ∼130°. (E) Examples of linear and straight filaments from 
reference-free means of PFKL segments with corresponding molecular models. (F) Model of CatP/RegL chimera with the catalytic domain of PFKP (gray) and 
the regulatory domain of PFKL (colored blue for dimer A and green for dimer B) interacting in the filament. (G) Negative-stain micrograph of the CatP/RegL 
in the presence of F6P. (H) Reconstruction of CatP/RegL at 25-Å resolution. (I) 90° light scattering at the 200 µg/ml CatP/RegL upon the addition of buffer 
alone (black line) or 2 mM F6P (gray line) at time 0. Data are representative of three determinations from two separate protein preparations.
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Figure 4. PFKL forms dynamic particles in MTLn3 rat breast cancer cells. (A) TIRF image of PFKL-EGFP expressing MTLn3 rat mammary adenocarcinoma 
cell from a time-lapse sequence acquired at 10 frames per second and 1-s (10 frames) and 5-s (50 frames) rolling averages highlighting docked PFKL-EGFP 
particles. (B) Kymographs showing docked PFKL-EGFP particles in the yellow box indicated in A. Black arrowheads correspond with the individual time 
points shown on the left. The plot shows fluorescence intensity of the two example particles highlighted by colored arrowheads as a function of time. (C) 
Docked PFKL-EGFP lifetime distribution from control cells (n = 306 particles from 10 cells). Histogram bin width was set according to the Freedman–Diaconis 
rule. The red line is a log-logistic fit of the lifetime distribution. The inset is a box plot of the mean particle docking time per cell for control cells or cells treated 
with 2-deoxyglucose (DOG; n = 298 particles from 10 cells) for 23 h. A t test was used to determine statistical significance. (D) Kymograph of the area 
in the red box indicated in A showing PFKL-EGFP particles docking at the similar location over the course of the video. (E) Single exposure and 5-s rolling 
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the docking site or sites is currently unknown, but we speculate 
that PFKL-EGFP particles are interacting with transmembrane 
ion transport proteins.
Although we cannot unambiguously confirm that these 
intracellular PFKL particles are filaments, several experimen-
tal observations strongly support this idea. First, PFKP-EGFP, 
which does not form filaments in vitro, did not form particles in 
cells but in contrast remained completely diffuse throughout the 
cytoplasm and indistinguishable from free EGFP (Fig. 4 E and 
Video 2). Second, consistent with our in vitro data showing that 
tetramers are necessary for filament assembly, we did not ob-
serve intracellular particles of PFKL-F638R-EGFP (Fig. 4 E), 
which does not form tetramers. Third, the CatP/RegL chimeric 
PFK1 that forms filaments in vitro was also seen as particles 
in cells (Fig. 4 E and Video 3). Hence, there was a strong ex-
perimental correlation between intracellular particle formation 
and in vitro filament assembly. Lastly, PFKL-EGFP particles 
did not appear elongated by resolution-limited microscopy, in-
dicating that if the punctate appearance indeed represents PFKL 
filaments, their length must be well below the Abbe resolution 
limit of the light microscope of ∼200 nm; i.e., intracellular 
PFKL filaments must have fewer than ∼15 tetramer subunits, 
in agreement with the length of filaments formed in vitro 
(Fig. 1 D). The fluorescence intensity of PFKL-EGFP particles 
was also relatively homogenous, further indicating a narrow fil-
ament length distribution.
Finally, we sought to determine whether PFKL-EGFP 
particle size and/or dynamics are regulated by glucose avail-
ability. Neither glucose starvation (not depicted) nor incubation 
of cells for 23 h with 2-deoxyglucose, a glucose analogue that 
cannot be metabolized, had a discernable impact on punctae 
size, dynamics, or membrane docking (Fig. 4 C). While exam-
ining the impact of metabolic ligands of PFK1 on the dynamics 
of PFKL-EGFP particles, we found that the addition of citrate, 
an allosteric inhibitor of PFK1, to the media induced the forma-
tion of large PFKL-EGFP–positive structures that we termed 
citrate-induced punctae (CIP). By confocal microscopy, PFKL-
EGFP appeared diffuse in the cytoplasm of MTLn3 cells grown 
in control medium (Fig. 5 A and Video 4). Addition of 10 mM 
citrate induced the formation of μm-scale PFKL-EGFP punctae 
with a mean ± SD diameter of 0.39 ± 0.15 µm (n = 24 total 
cells from three independent preparations; Fig. S3 D) within 4 
min. The formation of these structures was reversible, as CIP 
disappeared within minutes of returning cells to normal growth 
medium. Fusion of smaller particles to form larger particles was 
occasionally observed (Fig. 5, B and B′). CIP were specific to 
cells expressing PFKL-EGFP as they did not form in MTLn3 
expressing PFKP-EGFP (Fig. 5 C). CIP appeared similar in size 
and morphology to stress granules, P-bodies, and aggresomes 
(Mahboubi and Stochaj, 2017), suggesting that PFKL-EGFP 
can undergo a phase transition upon citrate challenge (Li et al., 
2012). The significance and function of CIP are currently un-
known but are important to resolve in future studies.
To our knowledge, this is the first study showing regulated 
assembly of a glycolytic enzyme into filamentous structures. The 
substrate-dependent filament assembly of PFKL and the align-
ment of tetramers in filaments with an exposed catalytic site sug-
gest that the enzyme is an active state in assembled polymers. 
averages for MTLn3 cells expressing EGFP or various EGFP-PFK1 constructs as labeled. The frame rate of time-lapse sequences was: EGFP, 2.6 frames per 
second; PFKP-EGFP, 1.5 frames per second; PFKL-F638R-EGFP, 2.8 frames per second; CatP/RegL-EGFP, 2.9 frames per second. Higher-magnification im-
ages of the areas of the red boxes in the CatP/RegL-EGFP cells highlight a docked particle. Data are representative of three independent cell preparations. 
Figure 5. Citrate reversibly induces the 
formation of large PFKL­EGFP punctae. (A) 
Spinning-disk confocal image of PFKL-EGFP–
expressing MTLn3 cells from a time-lapse se-
quence acquired at two frames per minute. 
Cells were imaged in growth medium for 5 
min before the addition of 10 mM citrate. After 
imaging for 5 min, the citrate-containing me-
dium was replaced with growth medium, and 
cells were imaged for an additional 5 min. 
Medium, image directly before the addition 
of 10 mM citrate; citrate, image 4 min after 
the addition of citrate; washout, image 5 min 
after removal of citrate-containing buffer. (B) 
Spinning-disk confocal z-stack of PFKL-EGFP–
expressing cells 4 min after the addition of 
10 mM citrate. (B′) Area of the red box in B at 
the time indicated after the addition of citrate. 
(C) Percentage of MTLn3 cells expressing ei-
ther PFKL-EGFP or PFKP-EGFP showing the for-
mation of large punctae in growth medium or 
4 min after the addition of 10 mM citrate. Error 
bars represent means ± SD. Data are represen-
tative of three independent cell preparations.
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When assembled into filaments, acetyl-CoA carboxylase (Mer-
edith and Lane, 1978; Beaty and Lane, 1983) and β-glucosidase 
(Gunning, 1965; Kim et al., 2005) are enzymatically active; how-
ever, bacterial CTP synthase is enzymatically inactive in poly-
mers, likely because of conformational constraints imposed by 
the filament assembly interactions (Barry et al., 2014).
Homomeric filament formation by PFKL could serve 
multiple, not necessarily exclusive functions. Filaments of other 
metabolic enzymes are proposed, but some are not conclusively 
determined, to function in scaffolding, regulated activity, and 
efficient substrate transfer. Filament formation may enable 
allosteric regulation of activity, perhaps for selective roles of 
the liver isoform in gluconeogenesis. Finally, PFKL filaments 
could allow for localized ATP production in cells. A subset 
of PFKL-EGFP particles localize near the plasma membrane 
(Fig.  4, A–D), where localized ATP production by glycolysis 
could support processes including protrusion, endocytosis, and 
the activity of ATP-dependent ion transporters and channels. 
Proteomics analyses indicate that several glycolytic enzymes, 
including pyruvate kinase, aldolase, and lactate dehydroge-
nase, localize in pseudopodia or invadopodia (Beckner et al., 
1990; Jia et al., 2005; Attanasio et al., 2011), and a plasma 
membrane– localized glycolytic metabolon was reported to en-
able vessel sprouting of endothelial cells (De Bock et al., 2013) 
and to generate localized energy in neurons for synaptic trans-
mission (Jang et al., 2016). Several glycolytic enzymes, such as 
PFKM and aldolase, associate with the cytoskeleton, where this 
interaction regulates enzyme localization and activity (Clarke 
and Masters, 1975; Wang et al., 1996). Thus, enzymes that do 
not form filaments may bind to filamentous cytoskeletal struc-
tures instead. Further studies are needed to resolve the function 
of PFKL filaments, with the distinct role of glycolysis in ATP 
production perhaps providing an important determinant. More-
over, our findings open a clinically relevant new direction for 
determining whether PFKL filaments regulate metabolic pro-
gramming in diseases such as cancer.
Materials and methods
Cloning, expression, and purification of recombinant human  
PFK1 isoforms
The Homo sapiens cDNA encoding the 780-amino-acid isoform b of 
PFKL (NP_002617) and the 780-amino-acid isoform 2 of the mus-
cle isoform PFKM (NP_000280) were cloned into pFastBac HTa or 
pFastBac HTb vectors, respectively. PFKL point mutants at the sugar 
substrate binding site H199Y and at the tetramer interface F638R were 
generated by using a commercially available site-directed mutagenesis 
kit (QuikChange Lightning; Agilent Technologies). DNA primers were 
designed using an online primer design tool (Agilent Technologies) 
and were purchased from Elim Biopharmaceuticals. Cloning of human 
PFKP was previously described (Webb et al., 2015). The chimera of 
PFKP and PFKL was generated by Gibson Assembly (New England 
Biolabs, Inc.). Baculovirus expression and PFK1 purification were per-
formed as previously described (Webb et al., 2015). In brief, 200–500 
million sf21 cells were used to express PFK1 at a multiplicity of in-
fection of 2 for 48 h. Cells were pelleted by low-speed centrifugation 
(1,000 g), then media was discarded, and pellets were stored at −80°C 
until the time of purification. Cell pellets were defrosted on ice, resus-
pended in 50 ml lysis buffer per 200 million cells (20 mM Tris-HCl, 
pH 7.5, 50 mM potassium phosphate, 1 mM 2-mercaptoethanol, 10% 
glycerol, 10 mM imidazole, and cOmplete Protease Inhibitor Cocktail 
[Roche]). Cells were lysed with ∼15 passes of a Dounce homogenizer, 
and debris was removed by centrifugation. The supernatant was incu-
bated with Talon resin (Takara Bio Inc.) and then washed with 20 bed 
volumes of lysis buffer, and PFK1 was eluted with a minimal volume of 
elution buffer (lysis buffer with 100 mM imidazole). Fractions contain-
ing protein were pooled and dialyzed into a buffer containing 20 mM 
Hepes, pH 7.5, 100 mM potassium chloride, 1 mM dithiothreitol, 
1 mM ATP, 1 mM magnesium chloride, and 5% glycerol. Protein con-
centration was determined using a Bradford Protein Assay kit (Thermo 
Fisher Scientific). After purification, PFK1 was stored on ice in a 4°C 
fridge. The sequences of PFKL, PFKP, and CatP/RegL were aligned 
using Clustal Omega (Sievers et al., 2011).
PFK1 activity assays
PFK1 activity was determined using an auxiliary enzyme assay (Brüser 
et al., 2012) with kinetic analysis using 200-µl reactions containing 
50  mM Tris-HCl, pH 7.4, 100  mM KCl, 10  mM MgCl2, 0.15  mM 
NADH, 0.675 U/ml aldolase, 5 U/ml triosephosphate isomerase, and 
2 U/ml glycerol phosphate dehydrogenase. ATP and F6P were used 
as indicated. Auxiliary enzymes were desalted using an Amicon 
Ultracel-10K Centrifugal Filter Unit (EMD Millipore) before use. The 
temperature was equilibrated to 25°C for 10 min before initiating the 
reaction with the addition of magnesium chloride. The absorbance at 
340 nm was measured using a SpectraMax M5 microplate reader (Mo-
lecular Devices). Kinetic parameters were generated by linear regres-
sion analysis of the Michalas-Menton or Hill equations using Prism 
(GraphPad Software) and are the mean of a minimum of three measure-
ments from two independent preparations of protein. One unit of activ-
ity was defined as the amount of enzyme that catalyzed the formation of 
1 mmol of fructose 1,6-bisphosphate per minute at 25°C.
TEM
20 µl of 50 µg/ml PFK1 was applied to glow-discharged carbon-coated 
grids and stained with 2% (wt/vol) uranyl acetate. Grids were exam-
ined and photographed with a 100CX II transmission electron micro-
scope (JEOL). For estimation of size of PFK1 particles and filaments, 
the length and width of individual particles from TEM images were 
measured using FIJI software (ImageJ; National Institutes of Health; 
Schindelin et al., 2012). The mean length and width ± SD are reported.
3D EM
For both PFKL and the PFKP/PFKL chimera, purified protein was con-
centrated to 0.5 mg/ml. Final concentrations of 2 mM F6P and 20 mM 
(NH4)SO4 were then added to the protein, and the assembly reaction 
was left to proceed for 10 min at room temperature. 3.5 µl of this re-
action mixture was then spotted onto a 400 mesh glow-discharged 
copper-coated grid using a 0.7% uranyl formate solution. Electron mi-
crographs were acquired on a Tecnai T12 microscope (FEI) operating 
at 120 kV at 52,000× magnification on a Gatan US4000 charge- coupled 
device camera with a 2.07 Å/px.
For both reconstructions, images were collected with Leginon 
(Suloway et al., 2005). Contrast transfer function (CTF) parameters 
were estimated using CTF FIND3 (Rohou and Grigorieff, 2015) with 
a defocus range of 0.6–1.4 µm. Polymer assemblies were manually 
picked in Appion (Lander et al., 2009). Particle boxing was performed 
in Appion using a 240-px box with an 80-Å helical step for both con-
structs, and CTF correction was performed by phase-flipping. For 
PFKL, 297 images were acquired, resulting in 25,364 segments cor-
responding with ∼31,700 phosphofructokinase tetramers. For CatP/
RegL, 96 images were acquired, resulting in 5,206 segments corre-
sponding with ∼6,500 PFK tetramers. 2D classification was performed 
in Relion (Scheres, 2012), and poorly behaved classes (poorly defined 
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features or obvious kinks in the filament) were excluded from 3D re-
constructions. The final datasets consisted of 9,324 segments for PFKL 
and 5,206 segments for CatP/RegL.
The Iterative Helical Real Space Reconstruction (IHR SR) 
method (Egelman, 2010) in Spider (Shaikh et al., 2008) was used for 
helical reconstruction. We modified the standard IHR SR protocol for 
gold-standard refinement, with all overlapping segments from a given 
filament assigned to the same half group to prevent overfitting. For 
the CatP/RegL reconstruction, a featureless cylinder was subject to 26 
rounds of gold-standard refinement (Scheres and Chen, 2012). This re-
sulted in a 26-Å converged map, with 221.6° azimuthal rotation and 83 
Å helical rise as the final helical parameters. For the PFKL reconstruc-
tion, the final PFKP/PFKL map filtered to 50 Å was used as an initial 
model for gold-standard refinement. After 15 rounds, this resulted in a 
25-Å converged map, with 221.5° azimuthal rotation and 82.8 Å helical 
rise as the final helical parameters.
90° light scattering
PFK1 polymerization was measured by 90°-angle light scattering in 
a Shimadzu RF-5301PC spectrofluorophotometer with 350-nm exci-
tation and emission wavelengths and 1.5-nm slit width at 25°C. PFK1 
was added at a final concentration up to 500 µg/ml (6 µM) as specified. 
Data were collected for ∼2 min to establish a baseline. Buffer or F6P 
was added to the cuvette from a 50× stock and gently mixed by pi-
petting. The elapsed time for the addition of substrate was ∼20 s. The 
reading at time 0 was the first reading after the addition of buffer or F6P 
with data collected every second. The change in light scattering relative 
to the maximal signal was plotted as a function of time.
Plasmid generation, transfection, cell culture, and microscopy
To generate PFK1 constructs with a carboxy-terminal EGFP tag, cDNA 
for wild-type and mutant PFKL and wild-type PFKP were cloned into 
pEGFP N2 and N1 vectors, respectively. The integrity of EGFP-tagged 
PFK1 was confirmed by Western blot analysis of total cell lysates of 
293FT cells using rabbit anti-GFP (A-11122; 1DB-001-0000868907; 
Invitrogen) and mouse anti-actin clone C4 (MAB1501; 1DB-001-
0000850281; EMD Millipore) antibodies (Fig. S3 E). MTLn3 rat mam-
mary adenocarcinoma cells (Segall et al., 1996) were maintained in 
high-glucose MEM α media supplemented with 10% heat- inactivated 
fetal bovine serum and 1× penicillin/streptomycin at 37°C and 5% CO2. 
Cells were tested for mycoplasma contamination before use (DNA 
Diagnostics Center). Fluorescently tagged PFK1 constructs were ex-
pressed by transfecting plasmid DNA into cells using FuGENE HD 
(Promega) as previously described (Webb et al., 2015). Cells were 
treated with 1  mM 2-deoxyglucose (Sigma-Aldrich) in cOmplete 
growth medium for 23 h. For acute treatment of cells with 10 mM ci-
trate (Sigma-Aldrich), citrate was added from a 1 M, pH 7.4, stock 
directly to growth medium.
For live-cell microscopy, cells were grown in 35-mm glass- 
bottom dishes (MatTek Corporation). TIRF images were acquired 
on a 37°C environmentally controlled inverted microscope stand (Ti; 
Nikon) equipped with a motorized TIRF illuminator (Nikon), an iXon 
electron-multiplying charge-coupled device camera (Andor Technol-
ogy), and a 100× 1.49 NA CFI Apochromat TIRF objective (Nikon) 
using 1.5× intermediate magnification optimized for live-cell imaging. 
Confocal images were acquired with a 60× Plan Apochromat TIRF 
objective (Nikon) 1.49 NA oil immersion objective on an inverted mi-
croscope system (Eclipse Ti Perfect Focus System; Nikon) equipped 
with a spinning-disk confocal scanner unit (Borealis-modified CSU-
X1; Yokogawa Electric Corporation; Spectral Applied Research), a 
multipoint stage (MS-2000; Applied Scientific Instruments), and a 
cMyo cooled charge-coupled device camera (Photometrics; Stehbens 
et al., 2012). All microscope hardware was controlled by NIS Ele-
ments software 4.5 (Nikon), and image processing and analysis was 
performed in NIS Elements. Stationary PFKL-EGFP particles were 
identified by 1- or 5-s rolling averages generated by the “ND Image 
Average” function of NIS Elements. The lifetime of docked particles 
was estimated to be the time between the half-maximum intensities 
in 2 × 2–pixel regions of interest in which fluorescence intensity was 
measured as a function of time. The histogram and the log-logistic 
curve fit of the lifetime distribution was calculated in MAT LAB 
(MathWorks). Kymographs were generated from the “Show Slices 
View” in NIS Elements by building a stack of y-t views and displaying 
a maximum-intensity projection of 3–4 y-t views to suppress image 
noise essentially as described (Stehbens et al., 2014). Final figures 
were assembled in Illustrator CS5 (Adobe).
Online supplemental material
Fig. S1 shows the activity, TEM, and light scattering of purified re-
combinant wild-type and mutant PFK1. Fig. S2 shows the determi-
nation of the PFKL filament structure. Fig. S3 shows the sequence, 
purification, and activity of CatP/RegL, size distribution of CIP, and 
immunoblot of PFK1-EGFP constructs. Video  1 shows how PFKL-
EGFP forms dynamic particles with punctate localization in cells and 
corresponds with Fig. 4 (A–D). Video 2 shows how PFKP-EGFP is 
diffuse in cells and corresponds with Fig.  4  E.  Video  3 shows how 
CatP/RegL-EGFP forms dynamic particles with punctate localization 
in cells and corresponds with Fig.  4  E.  Video  4 shows how citrate 
reversibly induces the formation of large PFKL-EGFP punctae and 
corresponds with Fig. 5 A.
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